A
Alcista
Alcista · 25%AZTA
$34.77
Precio del escenario
$36.520
-0.650 (-1.78%)Al cierre
Loading chart…
- Máximo
- 37.110
- Apertura
- 36.950
- Precio medio ponderado por volumen
- 36.28
- Volumen
- 1.22M
- Capitalización
- 2.81B
- Mínimo
- 35.195
- Importe
- 44.16M
- EV/EBITDA, TTM
- 36.27
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Análisis de IA of Azenta, Inc. (AZTA)
MantenerAzenta Inc is currently a hold. The stock is priced at $37.72, which is above the analyst price target of $35, indicating potential overvaluation. The recent RSI of 56.115 suggests that the stock is neither overbought nor oversold, but the negative sentiment from ongoing investigations into securities claims could pose risks.
Métricas de valoración
El PER previsto actual de Azenta, Inc. (AZTA) es 29.07, frente a su media de 5 años de 186.89.
Escenarios de precio de Alphio AI para AZTA
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Ballenas con AZTA en cartera
Cronología de eventos
Noticias
7.010-10PRnewswireRosen Law Firm Investigates Securities Claims Against Azenta, Inc.
7.010-06PRnewswireRosen Law Firm Investigates Azenta Securities Claims
7.009-29PRnewswireRosen Law Firm Investigates Securities Claims for Azenta, Inc.
8.509-04PRnewswireAzenta Receives Full Repayment of $35 Million Loan
7.009-03PRnewswirePomerantz LLP Investigates Azenta for Securities Fraud
Preguntas frecuentes sobre AZTA, respondidas por Alphio AI
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software. It operates in the Healthcare sector (SPECIAL INDUSTRY MACHINERY, NEC industry).
Azenta Inc is currently a hold. The stock is priced at $37.72, which is above the analyst price target of $35, indicating potential overvaluation. The recent RSI of 56.115 suggests that the stock is neither overbought nor oversold, but the negative sentiment from ongoing investigations into securities claims could pose risks.
Comunidad
Más ↗
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.